HINDUSTAN UNILEVER LTD. vs NATH BIO-GENES (I) LTD

A side-by-side comparison of HINDUSTAN UNILEVER LTD. (HINDUNILVR) and NATH BIO-GENES (I) LTD (NATHBIOGEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, HINDUSTAN UNILEVER LTD. leads HINDUNILVR vs NATHBIOGEN on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth11
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

30.73
P/E ratio
6.99
10.55
P/B ratio
0.46
2.04%
Dividend yield
1.30%
₹64.01
EPS
₹21.91

Profitability

HINDUNILVR takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

31.00%
Return on equity
5.47%
28.00%
Return on capital
7.00%
23.00%
EBITDA margin
12.00%
23.36%
Net margin
9.44%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

2.10%
Revenue CAGR (3Y)
23.89%
14.08%
Profit CAGR (3Y)
6.27%

Size & financial health

HINDUNILVR takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.63L Cr
Market cap
₹292 Cr
₹64,468 Cr
Revenue
₹445 Cr
₹15,059 Cr
Net profit
₹42 Cr
0.03
Debt / equity
0.18
HINDUSTAN UNILEVER LTD.
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 92.4%"]
  • ["Stock is trading at 9.69 times its book value", "The company has delivered a poor sales growth of 6.51% over past five years.", "Earnings include an other income of Rs.4,933 Cr."]
NATH BIO-GENES (I) LTD
  • + ["Stock is trading at 0.44 times its book value", "Debtor days have improved from 110 to 70.0 days."]
  • ["Tax rate seems low", "Company has a low return on equity of 5.93% over last 3 years.", "Earnings include an other income of Rs.15.2 Cr.", "Dividend payout has been low at 9.52% of profits over last 3 years"]
HINDUSTAN UNILEVER LTD. full analysis NATH BIO-GENES (I) LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

HINDUNILVR vs NATHBIOGEN: Share Price, Valuation & Which to Buy | DocStoX